Evidence map›Paper›PMID 36418344›Full record

ArticleBlood cancer journal2022

The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis.

Sameer A Parikh, Sara J Achenbach, Kari G Rabe, Aaron D Norman, Nicholas J Boddicker, Janet E Olson, Timothy G Call, James R Cerhan, Celine M Vachon, Neil E Kay and 4 more

Open access · goldAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Risk of Incident Melanoma Among Individuals With Low-Count Monoclonal B-Cell Lymphocytosis.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 1 country.

Sameer A ParikhDivision of Hematology, Mayo Clinic, Rochester, MN, USA. parikh.sameer@mayo.edu.ORCID 0000-0002-3221-7314
Sara J AchenbachDivision of Computational Biology, Mayo Clinic, Rochester, MN, USA.
Kari G RabeDivision of Computational Biology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-7313-1875
Aaron D NormanDivision of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN, USA.
Nicholas J BoddickerDivision of Computational Biology, Mayo Clinic, Rochester, MN, USA.
Janet E OlsonDivision of Epidemiology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0003-4944-7789
Timothy G CallDivision of Hematology, Mayo Clinic, Rochester, MN, USA.
James R CerhanDivision of Epidemiology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-7482-178X
Celine M VachonDivision of Epidemiology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-1962-9322
Neil E KayDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-5951-5055
Esteban BraggioDepartment of Hematology and Oncology, Mayo Clinic, Phoenix, AZ, USA.
Curtis A HansonDepartment of Laboratory Medicine and Pathology, Division of Hematopathology, Mayo Clinic, Rochester, MN, USA.
Susan L SlagerDivision of Hematology, Mayo Clinic, Rochester, MN, USA.ORCID 0000-0002-5173-4712
Tait D ShanafeltDepartment of Medicine, Division of Hematology, Stanford University, Stanford, CA, USA.
Mayo Clinic in Arizona · USMayo Clinic · USStanford University · USWinnMed · US

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI AKHILESH PANDEY · 1985 to 2026
$151.3M
The Role of Monocytes in non-Hodgkin LymphomaP50CA097274 · NCI · UNIVERSITY OF IOWA · PI LENTZ, STEVEN R · 2002 to 2021
$45.7M
Genetic Epidemiology of non-Hodgkin LymphomaR01CA200703 · NCI · MAYO CLINIC ROCHESTER · PI CERHAN, JAMES R · 2016 to 2020
$3.3M
Prevalence, etiology, and clinical implications of low count monoclonal B-cell lymphocytosis (MBL)R01AG058266 · NIA · MAYO CLINIC ROCHESTER · PI SHANAFELT, TAIT D, SLAGER, SUSAN L · 2018 to 2022
$3.2M
Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology ProjectR33AG058738 · NIA · MAYO CLINIC ROCHESTER · PI LEBRASSEUR, NATHAN K, OLSON, JANET E · 2020 to 2022
$2.4M
Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology ProjectR21AG058738 · NIA · MAYO CLINIC ROCHESTER · PI LEBRASSEUR, NATHAN K, OLSON, JANET E · 2018 to 2019
$437k
NCI NIH HHS P30 CA015083NCI NIH HHS P50 CA097274NCI NIH HHS R01 CA200703NIA NIH HHS R01 AG058266NIA NIH HHS R21 AG058738NIA NIH HHS R33 AG058738
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19LymphocytosisNeoplasms, Plasma CellHumans

Identifiers

PMID36418344
PMCPMC9684458
OpenAlexW4309701406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.